Hanna, Glenn
eCommons Login: GJH6
first name: Glenn
last name: Hanna
coauthor of: Haddad, Robert
coauthor of: Rettig, Eleni
coauthor of: Uppaluri, Ravindra
coauthor of: Schoenfeld, Jonathan
coauthor of: Margalit, Danielle
full name: Glenn J Hanna, M.D.
has faculty rank: Associate Professor
has network: selected publications
has network: research areas
has network: coauthor of
has network: similar to
latitude: 42.33700000000000
longitude: -71.11000000000000
Person ID: 90514
person in primary position: Associate Professor of Medicine
physical neighbor: Afdhal, Nezam
physical neighbor: Bardia, Amit
physical neighbor: Fischer, Edwin
physical neighbor: Hamdan, Allen
physical neighbor: Lin, Samuel
similar to: Haddad, Robert
similar to: Faquin, William
similar to: Faden, Daniel
similar to: Rettig, Eleni
similar to: Richmon, Jeremy
type: Agent
type: Person
selected publications: Authorship 1834445
selected publications: Authorship 1815011
selected publications: Authorship 1834245
selected publications: Authorship 1835173
selected publications: Authorship 1848859
selected publications: Authorship 1833561
selected publications: Authorship 1831398
selected publications: Authorship 1826292
selected publications: Authorship 1846252
selected publications: Authorship 1752686
selected publications: Authorship 1823631
selected publications: Authorship 1747712
selected publications: Authorship 1744459
selected publications: Authorship 1720959
selected publications: Authorship 1741808
selected publications: Authorship 1742626
selected publications: Authorship 1743120
selected publications: Authorship 1748274
selected publications: Authorship 1733758
selected publications: Authorship 1729257
selected publications: Authorship 1733851
selected publications: Authorship 1717516
selected publications: Authorship 1715551
selected publications: Authorship 1702443
selected publications: Authorship 1684367
selected publications: Authorship 1656596
selected publications: Authorship 1684321
selected publications: Authorship 1662612
selected publications: Authorship 1629841
selected publications: Authorship 1733476
selected publications: Authorship 1649233
selected publications: Authorship 1638723
selected publications: Authorship 1633220
selected publications: Authorship 1623931
selected publications: Authorship 1622956
selected publications: Authorship 1610561
selected publications: Authorship 1618428
selected publications: Authorship 1616634
selected publications: Authorship 1614586
selected publications: Authorship 1611117
selected publications: Authorship 1590331
selected publications: Authorship 1601663
selected publications: Authorship 1584392
selected publications: Authorship 1563150
selected publications: Authorship 1588166
selected publications: Authorship 1592161
selected publications: Authorship 1570445
selected publications: Authorship 1583925
selected publications: Authorship 1572808

eCommons Login
tag name: catalyst:eCommonsLogin
type: DatatypeProperty

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

physical neighbor
tag name: prns:physicalNeighborOf
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 3
tag name: vivo:address3
type: DatatypeProperty

city
tag name: vivo:addressCity
type: DatatypeProperty
type: FunctionalProperty

postal code
tag name: vivo:addressPostalCode
type: DatatypeProperty
type: FunctionalProperty

state or province
tag name: vivo:addressState
type: DatatypeProperty
type: FunctionalProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

Department
type: Class

Division
type: Class

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

middle name or initial
tag name: vivo:middleName
type: DatatypeProperty
type: FunctionalProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Authorship 1049248
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Frameshift events predict anti-PD-1/L1 response in head and neck cancer.

Authorship 1060692
type: Authorship
author rank in publication: 5
linked author: Hanna, Glenn
linked information resource: CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.

CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.
PubMed Identifier: 29700887
author list: Schaefer IM, Dal Cin P, Landry LM, Fletcher CDM, Hanna GJ, French CA
published in: Genes, chromosomes & cancer
information resource reference: CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies. Genes Chromosomes Cancer. 2018 09; 57(9):446-451.
journal title abbreviation: Genes Chromosomes Cancer
publication date: 2018-08-14T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1073226
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.

Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.
PubMed Identifier: 29884406
author list: Hanna GJ, Kofman ER, Shazib MA, Woo SB, Reardon B, Treister NS, Haddad RI, Cutler CS, Antin JH, Van Allen EM, Uppaluri R, Soiffer RJ
published in: Oral oncology
information resource reference: Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors. Oral Oncol. 2018 06; 81:1-9.
journal title abbreviation: Oral Oncol
publication date: 2018-04-10T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1077607
type: Authorship
author rank in publication: 9
linked author: Hanna, Glenn
linked information resource: Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.

Authorship 1077981
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Unresolved, atraumatic breast hematoma: post-irradiation or secondary breast angiosarcoma.

Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.
PubMed Identifier: 29960819
author list: Schoenfeld JD, Gjini E, Rodig SJ, Tishler RB, Rawal B, Catalano PJ, Uppaluri R, Haddad RI, Hanna GJ, Chau NG, Rabinowits G, Lorch J, Jo VY, Krane JF, Goguen LA, Annino DJ, Abdelrahman S, Lipschitz M, Margalit DN
published in: International journal of radiation oncology, biology, physics
information resource reference: Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2018 09 01; 102(1):137-145.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2018-06-29T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1083713
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Human papillomavirus and oropharyngeal cancer.

Human papillomavirus and oropharyngeal cancer.
PubMed Identifier: 30049422
author list: Villa A, Hanna GJ
published in: Current problems in cancer
information resource reference: Human papillomavirus and oropharyngeal cancer. Curr Probl Cancer. 2018 09; 42(5):466-475.
journal title abbreviation: Curr Probl Cancer
publication date: 2018-06-27T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1090307
type: Authorship
author rank in publication: 13
linked author: Hanna, Glenn
linked information resource: Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors.

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors.
PubMed Identifier: 30150660
author list: Miao D, Margolis CA, Vokes NI, Liu D, Taylor-Weiner A, Wankowicz SM, Adeegbe D, Keliher D, Schilling B, Tracy A, Manos M, Chau NG, Hanna GJ, Polak P, Rodig SJ, Signoretti S, Sholl LM, Engelman JA, Getz G, Jänne PA, Haddad RI, Choueiri TK, Barbie DA, Haq R, Awad MM, Schadendorf D, Hodi FS, Bellmunt J, Wong KK, Hammerman P, Van Allen EM
published in: Nature genetics
information resource reference: Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors. Nat Genet. 2018 09; 50(9):1271-1281.
journal title abbreviation: Nat Genet
publication date: 2018-08-27T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1091311
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer.

Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer.
PubMed Identifier: 30185662
author list: Hanna GJ, Kacew A, Chau NG, Shivdasani P, Lorch JH, Uppaluri R, Haddad RI, MacConaill LE
published in: JCI insight
information resource reference: Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer. JCI Insight. 2018 09 06; 3(17).
journal title abbreviation: JCI Insight
publication date: 2018-09-06T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.
PubMed Identifier: 30220316
author list: Sridharan V, Rahman RM, Huang RY, Chau NG, Lorch JH, Uppaluri R, Haddad RI, Hanna GJ, Schoenfeld JD
published in: Oral oncology
information resource reference: Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma. Oral Oncol. 2018 10; 85:29-34.
journal title abbreviation: Oral Oncol
publication date: 2018-08-17T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1093414
type: Authorship
author rank in publication: 8
linked author: Hanna, Glenn
linked information resource: Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.

Faden, Daniel
eCommons Login: DLF17
first name: Daniel
last name: Faden
full name: Daniel Lawrence Faden, M.D.
has faculty rank: Associate Professor
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 174857
person in primary position: Associate Professor of Otolaryngology Head and Neck Surgery
type: Agent
type: Person
preferred title: Associate Professor of Otolaryngology Head and Neck Surgery

Otolaryngology Head and Neck Surgery
type: Department
type: Organization

Authorship 1134543
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Everolimus in Anaplastic Thyroid Cancer: A Case Series.

Everolimus in Anaplastic Thyroid Cancer: A Case Series.
PubMed Identifier: 30863722
author list: Harris EJ, Hanna GJ, Chau N, Rabinowits G, Haddad R, Margalit DN, Schoenfeld J, Tishler RB, Barletta JA, Nehs M, Janne P, Huang J, Groden P, Kacew A, Lorch J
published in: Frontiers in oncology
information resource reference: Everolimus in Anaplastic Thyroid Cancer: A Case Series. Front Oncol. 2019; 9:106.
journal title abbreviation: Front Oncol
publication date: 2019-02-26T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Head and Neck Neoplasms
MeSH DescriptorUI: D006258
MeSH semantic group name: Disorders
number of authors: 888
number of publications: 3078
uniqueness weight: 0.34615
type: Concept

Carcinoma, Adenoid Cystic
MeSH DescriptorUI: D003528
MeSH semantic group name: Disorders
number of authors: 140
number of publications: 265
uniqueness weight: 0.795194
type: Concept

Salivary Gland Neoplasms
MeSH DescriptorUI: D012468
MeSH semantic group name: Disorders
number of authors: 139
number of publications: 321
uniqueness weight: 0.734094
type: Concept

Authorship 1143539
type: Authorship
author rank in publication: 11
linked author: Hanna, Glenn
linked information resource: Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.
PubMed Identifier: 30954880
author list: Kacew AJ, Harris EJ, Lorch JH, Haddad RI, Chau NG, Rabinowits G, LeBoeuf NR, Schmults CD, Thakuria M, MacConaill LE, Hanna GJ
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma. Eur J Cancer. 2019 05; 113:1-9.
journal title abbreviation: Eur J Cancer
publication date: 2019-04-04T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Oropharyngeal Neoplasms
MeSH DescriptorUI: D009959
MeSH semantic group name: Disorders
number of authors: 174
number of publications: 539
uniqueness weight: 0.639588
type: Concept

Papillomavirus Infections
MeSH DescriptorUI: D030361
MeSH semantic group name: Disorders
number of authors: 598
number of publications: 1806
uniqueness weight: 0.410654
type: Concept

Anaesthesia
type: Department
type: Organization

Medicine
type: Department
type: Organization

Pathology
type: Department
type: Organization

Radiation Oncology
type: Department
type: Organization

Surgery
type: Department
type: Organization

Gastroenterology
type: Division
type: Organization

Vascular Surgery
type: Division
type: Organization

Oncology
type: Division
type: Organization

Beth Israel Deaconess Medical Center
type: Organization

Brigham and Women's Hospital
type: Organization

Dana-Farber Cancer Institute
type: Organization

Massachusetts Eye and Ear Infirmary
type: Organization

Massachusetts General Hospital
type: Organization

Schoenfeld, Jonathan
eCommons Login: JDS17
first name: Jonathan
last name: Schoenfeld
full name: Jonathan Daniel Schoenfeld, M.D.
has faculty rank: Full Professor
latitude: 42.33510370000000
longitude: -71.10616490000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 73574
person in primary position: Professor of Radiation Oncology
type: Agent
type: Person
preferred title: Professor of Radiation Oncology

Authorship 1154686
type: Authorship
author rank in publication: 10
linked author: Hanna, Glenn
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/123251299

https://connects.catalyst.harvard.edu/Profiles/profile/123251299
PubMed Identifier: 31082494
author list: Margalit DN, Haddad RI, Tishler RB, Chau NG, Schoenfeld JD, Bakst RL, Misiukiewicz KJ, Gupta V, Posner M, Hanna GJ, Mahmood U, Rawal B, Catalano PJ, Rath L, Bacay A, McHugh P, Rabinowits G
published in: International journal of radiation oncology, biology, physics
information resource reference: A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys. 2019 09 01; 105(1):132-139.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2019-05-11T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource
label: A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck.

Fischer, Edwin
eCommons Login: EGF1
first name: Edwin
last name: Fischer
full name: Edwin Garvin Fischer, M.D.
has faculty rank: Other Faculty
latitude: 42.33700000000000
longitude: -71.11000000000000
Person ID: 85011
person in primary position: Corresponding Member of the Faculty of Neurosurgery
type: Agent
type: Person
preferred title: Corresponding Member of the Faculty of Neurosurgery

Bardia, Amit
eCommons Login: AB291
first name: Amit
last name: Bardia
full name: Amit Bardia, M.D.
has faculty rank: Associate Professor
latitude: 42.33700000000000
longitude: -71.11000000000000
Person ID: 90517
person in primary position: Associate Professor of Anaesthesia
type: Agent
type: Person
preferred title: Associate Professor of Anaesthesia

Margalit, Danielle
eCommons Login: DNM1
first name: Danielle
last name: Margalit
full name: Danielle Nina Margalit, M.D.
has faculty rank: Associate Professor
latitude: 42.33510370000000
longitude: -71.10616490000000
Person ID: 54905
person in primary position: Associate Professor of Radiation Oncology
type: Agent
type: Person
preferred title: Associate Professor of Radiation Oncology

Faquin, William
eCommons Login: WCF2
first name: William
last name: Faquin
full name: William Clay Faquin, M.D., Ph.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 15468
person in primary position: Professor of Pathology
type: Agent
type: Person
preferred title: Professor of Pathology

Lin, Samuel
eCommons Login: SJL19
first name: Samuel
last name: Lin
full name: Samuel J Lin, M.D.
has faculty rank: Associate Professor
latitude: 42.33700000000000
longitude: -71.11000000000000
Person ID: 38787
person in primary position: Associate Professor of Surgery
type: Agent
type: Person
preferred title: Associate Professor of Surgery

Afdhal, Nezam
eCommons Login: NHA1
first name: Nezam
last name: Afdhal
full name: Nezam Hassan Afdhal, M.D.
has faculty rank: Full Professor
latitude: 42.33700000000000
longitude: -71.11000000000000
Person ID: 4694
person in primary position: Charlotte F. and Irving W. Rabb Professor of Medicine
type: Agent
type: Person
preferred title: Charlotte F. and Irving W. Rabb Professor of Medicine

Hamdan, Allen
eCommons Login: ADH3
first name: Allen
last name: Hamdan
full name: Allen David Hamdan, M.D.
has faculty rank: Associate Professor
latitude: 42.33700000000000
longitude: -71.11000000000000
Person ID: 80594
person in primary position: Associate Professor of Surgery
type: Agent
type: Person
preferred title: Associate Professor of Surgery

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 129
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/113
predicate: selected publications
type: Network

research areas
maximum weight: 6.19334
minimum weight: 0.00357017
number of connections: 258
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/217
predicate: research areas
type: Network

coauthor of
maximum weight: 8.30529
minimum weight: 0.0278525
number of connections: 174
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/363
predicate: coauthor of
type: Network

similar to
maximum weight: 253.366
minimum weight: 29.0504
number of connections: 60
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/494
predicate: similar to
type: Network

Haddad, Robert
eCommons Login: RIH2
first name: Robert
last name: Haddad
full name: Robert I. Haddad, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 15867
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Authorship 1173039
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Oral keratosis of unknown significance shares genomic overlap with oral dysplasia.

Oral keratosis of unknown significance shares genomic overlap with oral dysplasia.
PubMed Identifier: 31295753
author list: Villa A, Hanna GJ, Kacew A, Frustino J, Hammerman PS, Woo SB
published in: Oral diseases
information resource reference: Oral keratosis of unknown significance shares genomic overlap with oral dysplasia. Oral Dis. 2019 Oct; 25(7):1707-1714.
journal title abbreviation: Oral Dis
publication date: 2019-07-23T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1174642
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
PubMed Identifier: 31345379
author list: Hanna GJ, Lau CJ, Mahmood U, Supplee JG, Mogili AR, Haddad RI, Jänne PA, Paweletz CP
published in: Oral oncology
information resource reference: Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer. Oral Oncol. 2019 08; 95:120-126.
journal title abbreviation: Oral Oncol
publication date: 2019-06-20T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1178183
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.

Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
PubMed Identifier: 31358520
author list: Mahal BA, Catalano PJ, Haddad RI, Hanna GJ, Kass JI, Schoenfeld JD, Tishler RB, Margalit DN
published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
information resource reference: Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2019 10; 28(10):1660-1667.
journal title abbreviation: Cancer Epidemiol Biomarkers Prev
publication date: 2019-07-29T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Rettig, Eleni
eCommons Login: EMR30
first name: Eleni
last name: Rettig
full name: Eleni M. Rettig, M.D.
has faculty rank: Assistant Professor
Person ID: 183557
person in primary position: Assistant Professor of Otolaryngology Head and Neck Surgery
type: Agent
type: Person
preferred title: Assistant Professor of Otolaryngology Head and Neck Surgery

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 1225816
type: Authorship
author rank in publication: 11
linked author: Hanna, Glenn
linked information resource: ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome.

ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome.
PubMed Identifier: 32068070
author list: Slevin MK, Wollison BM, Powers W, Burns RT, Patel N, Ducar MD, Starrett GJ, Garcia EP, Manning DK, Cheng J, Hanna GJ, Kaye KM, Van Hummelen P, Nag A, Thorner AR, DeCaprio JA, MacConaill LE
published in: The Journal of molecular diagnostics : JMD
information resource reference: ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome. J Mol Diagn. 2020 04; 22(4):476-487.
journal title abbreviation: J Mol Diagn
publication date: 2020-02-15T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1237926
type: Authorship
author rank in publication: 9
linked author: Hanna, Glenn
linked information resource: Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck.

Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck.
PubMed Identifier: 32251982
author list: Kacew AJ, Harris EJ, Lorch JH, Schoenfeld JD, Margalit DN, Kass JI, Tishler RB, Haddad RI, Hanna GJ
published in: Oral oncology
information resource reference: Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2020 06; 105:104676.
journal title abbreviation: Oral Oncol
publication date: 2020-04-03T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.
PubMed Identifier: 32283496
author list: Hanna GJ, Bae JE, Lorch JH, Schoenfeld JD, Margalit DN, Tishler RB, Haddad RI, Chau NG
published in: Oral oncology
information resource reference: Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma. Oral Oncol. 2020 07; 106:104690.
journal title abbreviation: Oral Oncol
publication date: 2020-04-11T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.
PubMed Identifier: 32310325
author list: Hanna GJ, Bae JE, Lorch JH, Haddad RI, Jo VY, Schoenfeld JD, Margalit DN, Tishler RB, Goguen LA, Annino DJ, Chau NG
published in: The oncologist
information resource reference: The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers. Oncologist. 2020 07; 25(7):598-608.
journal title abbreviation: Oncologist
publication date: 2020-04-20T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1240143
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.

Authorship 1241371
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.

Authorship 1257339
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
PubMed Identifier: 32557577
author list: Hanna GJ, Guenette JP, Chau NG, Sayehli CM, Wilhelm C, Metcalf R, Wong DJ, Brose M, Razaq M, Pérez-Ruiz E, Cohen EEW, Aggarwal R, Scholz C, Gualberto A, Ho AL
published in: Cancer
information resource reference: Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer. Cancer. 2020 09 01; 126(17):3972-3981.
journal title abbreviation: Cancer
publication date: 2020-06-18T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1258197
type: Authorship
author rank in publication: 6
linked author: Hanna, Glenn
linked information resource: Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy.

Authorship 1259871
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma.

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma.
PubMed Identifier: 32582722
author list: Hanna GJ, Kacew AJ, Tanguturi AR, Grote HJ, Vergara V, Brunkhorst B, Rabinowits G, Thakuria M, LeBoeuf NR, Ihling C, DeCaprio JA, Lorch JH
published in: Frontiers in medicine
information resource reference: Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma. Front Med (Lausanne). 2020; 7:198.
journal title abbreviation: Front Med (Lausanne)
publication date: 2020-06-05T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy.
PubMed Identifier: 32588077
author list: Danesh MJ, Mulvaney PM, Murakami N, Riella LV, Silk AW, Hanna GJ, Schmults CD
published in: Cancer immunology, immunotherapy : CII
information resource reference: Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy. Cancer Immunol Immunother. 2020 09; 69(9):1937-1941.
journal title abbreviation: Cancer Immunol Immunother
publication date: 2020-06-25T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1268120
type: Authorship
author rank in publication: 28
linked author: Hanna, Glenn
linked information resource: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
PubMed Identifier: 32665297
author list: Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, Spies NC, Lin T, Li T, Mulder DT, Hanna Y, Cirlan I, Pugh TJ, Mudianto T, Riley R, Zhou L, Jo VY, Stachler MD, Hanna GJ, Kass J, Haddad R, Schoenfeld JD, Gjini E, Lako A, Thorstad W, Gay HA, Daly M, Rodig SJ, Hagemann IS, Kallogjeri D, Piccirillo JF, Chernock RD, Griffith M, Griffith OL, Adkins DR
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. Clin Cancer Res. 2020 10 01; 26(19):5140-5152.
journal title abbreviation: Clin Cancer Res
publication date: 2020-07-14T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Corresponding Member of the Faculty of Neurosurgery
is primary position: true
position in department: Neurosurgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Corresponding Member of the Faculty of Neurosurgery
position in organization: Beth Israel Deaconess Medical Center

Authorship 1276169
type: Authorship
author rank in publication: 7
linked author: Hanna, Glenn
linked information resource: Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin.

Authorship 1278784
type: Authorship
author rank in publication: 6
linked author: Hanna, Glenn
linked information resource: A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.

Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin.
PubMed Identifier: 32815253
author list: Arbab M, Chen YH, Criscitiello S, Glass J, Fugazzotto JA, Killoran JH, Hanna G, Lorch J, Haddad RI, Margalit DN, Tishler RB, Schoenfeld JD
published in: Head & neck
information resource reference: Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin. Head Neck. 2020 12; 42(12):3670-3677.
journal title abbreviation: Head Neck
publication date: 2020-08-19T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.
PubMed Identifier: 32781104
author list: Mahmood U, Bang A, Chen YH, Mak RH, Lorch JH, Hanna GJ, Nishino M, Manuszak C, Thrash EM, Severgnini M, Sanborn M, Sridharan V, Margalit DN, Tishler RB, Busse PM, Willers H, Mamon HJ, Yoo HJ, Pai SI, Wirth LJ, Haddad RI, Chau NG, Schoenfeld JD
published in: International journal of radiation oncology, biology, physics
information resource reference: A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):134-144.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2020-08-08T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Charlotte F. and Irving W. Rabb Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Gastroenterology
sort order: 1
type: Position
HR job title: Charlotte F. and Irving W. Rabb Professor of Medicine
position in organization: Beth Israel Deaconess Medical Center

Authorship 1279568
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.
PubMed Identifier: 32852531
author list: Schoenfeld JD, Hanna GJ, Jo VY, Rawal B, Chen YH, Catalano PS, Lako A, Ciantra Z, Weirather JL, Criscitiello S, Luoma A, Chau N, Lorch J, Kass JI, Annino D, Goguen L, Desai A, Ross B, Shah HJ, Jacene HA, Margalit DN, Tishler RB, Wucherpfennig KW, Rodig SJ, Uppaluri R, Haddad RI
published in: JAMA oncology
information resource reference: Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial. JAMA Oncol. 2020 10 01; 6(10):1563-1570.
journal title abbreviation: JAMA Oncol
publication date: 2020-10-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1281811
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI).

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI).
PubMed Identifier: 32868898
author list: Hanna GJ, Ruiz ES, LeBoeuf NR, Thakuria M, Schmults CD, Decaprio JA, Silk AW
published in: British journal of cancer
information resource reference: Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI). Br J Cancer. 2020 11; 123(10):1535-1542.
journal title abbreviation: Br J Cancer
publication date: 2020-09-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1287692
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis.

Authorship 1288445
type: Authorship
author rank in publication: 9
linked author: Hanna, Glenn
linked information resource: Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab.

Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab.
PubMed Identifier: 32938212
author list: Bharmal M, Nolte S, Lebbé C, Mortier L, Brohl AS, Fazio N, Grob JJ, Pusceddu S, Hanna GJ, Hassel JC, Kiecker F, Ellers-Lenz B, Bajars M, Güzel G, Nghiem P, Hunger M, Schlichting M, Henry-Szatkowski M, D'Angelo SP
published in: Future oncology (London, England)
information resource reference: Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab. Future Oncol. 2020 Sep; 16(27):2089-2099.
journal title abbreviation: Future Oncol
publication date: 2020-09-17T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis.
PubMed Identifier: 32949282
author list: Park SI, Guenette JP, Suh CH, Hanna GJ, Chung SR, Baek JH, Lee JH, Choi YJ
published in: European radiology
information resource reference: The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis. Eur Radiol. 2021 Apr; 31(4):2048-2061.
journal title abbreviation: Eur Radiol
publication date: 2020-09-19T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1296643
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Rural patients with oral squamous cell carcinoma experience better prognosis and long-term survival.

Rural patients with oral squamous cell carcinoma experience better prognosis and long-term survival.
PubMed Identifier: 33096312
author list: Harris JA, Hunter WP, Hanna GJ, Treister NS, Menon RS
published in: Oral oncology
information resource reference: Rural patients with oral squamous cell carcinoma experience better prognosis and long-term survival. Oral Oncol. 2020 12; 111:105037.
journal title abbreviation: Oral Oncol
publication date: 2020-10-20T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1302379
type: Authorship
author rank in publication: 7
linked author: Hanna, Glenn
linked information resource: Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative radiation therapy.

Authorship 1303035
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.

Authorship 1303374
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.

Authorship 1303265
type: Authorship
author rank in publication: 6
linked author: Hanna, Glenn
linked information resource: The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.

Authorship 1304802
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: A model for training and evaluation of myringotomy and tube placement skills.

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.
PubMed Identifier: 33190021
author list: Hanna GJ, Rettig EM, Park JC, Varvares MA, Lorch JH, Margalit DN, Schoenfeld JD, Tishler RB, Goguen LA, Annino DJ, Haddad RI, Uppaluri R
published in: Oral oncology
information resource reference: Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19. Oral Oncol. 2021 01; 112:105087.
journal title abbreviation: Oral Oncol
publication date: 2020-11-06T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
PubMed Identifier: 33146897
author list: Campbell BR, Chen Z, Faden DL, Agrawal N, Li RJ, Hanna GJ, Iyer NG, Boot A, Rozen SG, Vettore AL, Panda B, Krishnan NM, Pickering CR, Myers JN, Guo X, Lang Kuhs KA
published in: Cancer
information resource reference: The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma. Cancer. 2021 02 15; 127(4):544-553.
journal title abbreviation: Cancer
publication date: 2020-11-04T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative radiation therapy.
PubMed Identifier: 33171164
author list: Chipidza FE, Thakuria M, Schoenfeld JD, Silk AW, Catalano PJ, Yoon CH, Hanna GJ, DeCaprio JA, Tishler RB, Margalit DN
published in: Journal of the American Academy of Dermatology
information resource reference: Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative radiation therapy. J Am Acad Dermatol. 2021 Mar; 84(3):875-877.
journal title abbreviation: J Am Acad Dermatol
publication date: 2020-11-07T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

A model for training and evaluation of myringotomy and tube placement skills.
PubMed Identifier: 21647901
author list: Malekzadeh S, Hanna G, Wilson B, Pehlivanova M, Milmoe G
published in: The Laryngoscope
information resource reference: A model for training and evaluation of myringotomy and tube placement skills. Laryngoscope. 2011 Jul; 121(7):1410-5.
journal title abbreviation: Laryngoscope
publication date: 2011-06-06T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.
PubMed Identifier: 33165928
author list: Cheng ML, Pectasides E, Hanna GJ, Parsons HA, Choudhury AD, Oxnard GR
published in: CA: a cancer journal for clinicians
information resource reference: Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions. CA Cancer J Clin. 2021 03; 71(2):176-190.
journal title abbreviation: CA Cancer J Clin
publication date: 2020-11-09T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
PubMed Identifier: 33359528
author list: Murakami N, Mulvaney P, Danesh M, Abudayyeh A, Diab A, Abdel-Wahab N, Abdelrahim M, Khairallah P, Shirazian S, Kukla A, Owoyemi IO, Alhamad T, Husami S, Menon M, Santeusanio A, Blosser CD, Zuniga SC, Soler MJ, Moreso F, Mithani Z, Ortiz-Melo D, Jaimes EA, Gutgarts V, Lum E, Danovitch GM, Cardarelli F, Drews RE, Bassil C, Swank JL, Westphal S, Mannon RB, Shirai K, Kitchlu A, Ong S, Machado SM, Mothi SS, Ott PA, Rahma O, Hodi FS, Sise ME, Gupta S, Leaf DE, Devoe CE, Wanchoo R, Nair VV, Schmults CD, Hanna GJ, Sprangers B, Riella LV, Jhaveri KD
published in: Kidney international
information resource reference: A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int. 2021 07; 100(1):196-205.
journal title abbreviation: Kidney Int
publication date: 2020-12-24T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Predictors of immunotherapy benefit in Merkel cell carcinoma.
PubMed Identifier: 33315984
author list: Kacew AJ, Dharaneeswaran H, Starrett GJ, Thakuria M, LeBoeuf NR, Silk AW, DeCaprio JA, Hanna GJ
published in: Oncotarget
information resource reference: Predictors of immunotherapy benefit in Merkel cell carcinoma. Oncotarget. 2020 Nov 24; 11(47):4401-4410.
journal title abbreviation: Oncotarget
publication date: 2020-11-24T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1312189
type: Authorship
author rank in publication: 8
linked author: Hanna, Glenn
linked information resource: Predictors of immunotherapy benefit in Merkel cell carcinoma.

Authorship 1314466
type: Authorship
author rank in publication: 47
linked author: Hanna, Glenn
linked information resource: A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.

Authorship 1315404
type: Authorship
author rank in publication: 8
linked author: Hanna, Glenn
linked information resource: Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck.

Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck.
PubMed Identifier: 33364395
author list: Harris EJ, Huang J, Carroll E, Lowe AC, Chau NG, Rabinowits G, Haddad R, Hanna GJ, Haddad T, Sanborn M, Kacew A, Lorch J
published in: Laryngoscope investigative otolaryngology
information resource reference: Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck. Laryngoscope Investig Otolaryngol. 2020 Dec; 5(6):1063-1069.
journal title abbreviation: Laryngoscope Investig Otolaryngol
publication date: 2020-10-27T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1317930
type: Authorship
author rank in publication: 28
linked author: Hanna, Glenn
linked information resource: Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.

Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
PubMed Identifier: 33397681
author list: Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, Spies NC, Lin T, Li T, Mulder DT, Hanna Y, Cirlan I, Pugh TJ, Mudianto T, Riley R, Zhou L, Jo VY, Stachler MD, Hanna GJ, Kass J, Haddad R, Schoenfeld JD, Gjini E, Lako A, Thorstad W, Gay HA, Daly M, Rodig SJ, Hagemann IS, Kallogjeri D, Piccirillo JF, Chernock RD, Griffith M, Griffith OL, Adkins DR
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. Clin Cancer Res. 2021 Jan 01; 27(1):357.
journal title abbreviation: Clin Cancer Res
publication date: 2021-01-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

The Inequitable Global Burden of Lip and Oral Cancers: Widening Disparities Across Countries.
PubMed Identifier: 33497647
author list: Harris JA, Ritchie CA, Hanna GJ, McCain JP, Ji YD
published in: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
information resource reference: The Inequitable Global Burden of Lip and Oral Cancers: Widening Disparities Across Countries. J Oral Maxillofac Surg. 2021 06; 79(6):1364-1372.
journal title abbreviation: J Oral Maxillofac Surg
publication date: 2020-12-29T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1324198
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: The Inequitable Global Burden of Lip and Oral Cancers: Widening Disparities Across Countries.

Authorship 1326015
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Value and Unmet Needs in Non-Invasive Human Papillomavirus (HPV) Testing for Oropharyngeal Cancer.

Development and Implementation of an Online Adaptive Stereotactic Body Radiation Therapy Workflow for Treatment of Intracardiac Metastasis.
PubMed Identifier: 33556580
author list: Shi DD, Liu KX, Hacker F, Hanna GJ, Kwong RY, Cagney DN, Mak RH, Singer L
published in: Practical radiation oncology
information resource reference: Development and Implementation of an Online Adaptive Stereotactic Body Radiation Therapy Workflow for Treatment of Intracardiac Metastasis. Pract Radiat Oncol. 2021 Jul-Aug; 11(4):e395-e401.
journal title abbreviation: Pract Radiat Oncol
publication date: 2021-02-06T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Value and Unmet Needs in Non-Invasive Human Papillomavirus (HPV) Testing for Oropharyngeal Cancer.
PubMed Identifier: 33540527
author list: Kacew AJ, Hanna GJ
published in: Cancers
information resource reference: Value and Unmet Needs in Non-Invasive Human Papillomavirus (HPV) Testing for Oropharyngeal Cancer. Cancers (Basel). 2021 Feb 02; 13(3).
journal title abbreviation: Cancers (Basel)
publication date: 2021-02-02T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1328338
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: Development and Implementation of an Online Adaptive Stereotactic Body Radiation Therapy Workflow for Treatment of Intracardiac Metastasis.

Effects of racial residential segregation on oral squamous cell carcinoma prognosis and survival.
PubMed Identifier: 34091188
author list: Harris JA, Hunter WP, Ji YD, Hanna GJ
published in: Oral oncology
information resource reference: Effects of racial residential segregation on oral squamous cell carcinoma prognosis and survival. Oral Oncol. 2021 08; 119:105364.
journal title abbreviation: Oral Oncol
publication date: 2021-06-03T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1362933
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.

Authorship 1362776
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: Effects of racial residential segregation on oral squamous cell carcinoma prognosis and survival.

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
PubMed Identifier: 34091189
author list: Hanna GJ, ONeill A, Cutler JM, Flynn M, Vijaykumar T, Clark JR, Wirth LJ, Lorch JH, Park JC, Mito JK, Lohr JG, Kaufman J, Burr NS, Zon LI, Haddad RI
published in: Oral oncology
information resource reference: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma. Oral Oncol. 2021 08; 119:105366.
journal title abbreviation: Oral Oncol
publication date: 2021-06-03T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1375915
type: Authorship
author rank in publication: 5
linked author: Hanna, Glenn
linked information resource: Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.

Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.
PubMed Identifier: 34265157
author list: Klein BA, Alves FA, de Santana Rodrigues Velho J, Vacharotayangul P, Hanna GJ, LeBoeuf NR, Shazib MA, Villa A, Woo SB, Sroussi H, Sonis S, Treister NS
published in: Oral diseases
information resource reference: Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors. Oral Dis. 2022 Jan; 28(1):9-22.
journal title abbreviation: Oral Dis
publication date: 2021-08-03T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1377821
type: Authorship
author rank in publication: 8
linked author: Hanna, Glenn
linked information resource: First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
PubMed Identifier: 34301810
author list: D'Angelo SP, Lebbé C, Mortier L, Brohl AS, Fazio N, Grob JJ, Prinzi N, Hanna GJ, Hassel JC, Kiecker F, Georges S, Ellers-Lenz B, Shah P, Güzel G, Nghiem P
published in: Journal for immunotherapy of cancer
information resource reference: First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study. J Immunother Cancer. 2021 07; 9(7).
journal title abbreviation: J Immunother Cancer
publication date: 2021-07-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1384279
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: Sicca syndrome associated with immune checkpoint inhibitor therapy.

Sicca syndrome associated with immune checkpoint inhibitor therapy.
PubMed Identifier: 34379884
author list: Harris JA, Huang K, Miloslavsky E, Hanna GJ
published in: Oral diseases
information resource reference: Sicca syndrome associated with immune checkpoint inhibitor therapy. Oral Dis. 2022 Nov; 28(8):2083-2092.
journal title abbreviation: Oral Dis
publication date: 2021-08-17T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1393867
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Preface.

Preface.
PubMed Identifier: 34503736
author list: Hanna GJ
published in: Hematology/oncology clinics of North America
information resource reference: Preface. Hematol Oncol Clin North Am. 2021 10; 35(5):xiii-xiv.
journal title abbreviation: Hematol Oncol Clin North Am
publication date: 2021-10-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1404034
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.
PubMed Identifier: 34667025
author list: Hanna GJ, O'Neill A, Shin KY, Wong K, Jo VY, Quinn CT, Cutler JM, Flynn M, Lizotte PH, Annino DJ, Goguen LA, Kass JI, Rettig EM, Sethi RKV, Lorch JH, Schoenfeld JD, Margalit DN, Tishler RB, Everett PC, Desai AM, Cavanaugh ME, Paweletz CP, Egloff AM, Uppaluri R, Haddad RI
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 2022 02 01; 28(3):468-478.
journal title abbreviation: Clin Cancer Res
publication date: 2021-10-19T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1419585
type: Authorship
author rank in publication: 10
linked author: Hanna, Glenn
linked information resource: Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomes.

Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomes.
PubMed Identifier: 34927307
author list: Tyan K, Bae JE, Lorch JH, Margalit DN, Tishler RB, Huynh MA, Jo VY, Haddad RI, Chau NG, Hanna GJ, Schoenfeld JD
published in: Head & neck
information resource reference: Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomes. Head Neck. 2022 03; 44(3):722-734.
journal title abbreviation: Head Neck
publication date: 2021-12-19T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1429785
type: Authorship
author rank in publication: 9
linked author: Hanna, Glenn
linked information resource: Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition.

Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition.
PubMed Identifier: 35105672
author list: Alhousami T, Diny M, Ali F, Shin J, Kumar G, Kumar V, Campbell JD, Noonan V, Hanna GJ, Denis GV, Monti S, Kukuruzinska MA, Varelas X, Bais MV
published in: Molecular cancer research : MCR
information resource reference: Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition. Mol Cancer Res. 2022 05 04; 20(5):712-721.
journal title abbreviation: Mol Cancer Res
publication date: 2022-05-04T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Radiation Oncology
is primary position: true
position in department: Radiation Oncology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Radiation Oncology
position in organization: Brigham and Women's Hospital

Authorship 1438997
type: Authorship
author rank in publication: 14
linked author: Hanna, Glenn
linked information resource: Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.

Authorship 1438436
type: Authorship
author rank in publication: 15
linked author: Hanna, Glenn
linked information resource: Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.

Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
PubMed Identifier: 35355358
author list: Arbab M, Chen YH, Tishler RB, Gunasti L, Glass J, Fugazzotto JA, Killoran JH, Sethi R, Rettig E, Annino D, Goguen L, Uppaluri R, Hsu C, Burke E, Hanna GJ, Lorch J, Haddad RI, Margalit DN, Schoenfeld JD
published in: Head & neck
information resource reference: Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers. Head Neck. 2022 06; 44(6):1442-1452.
journal title abbreviation: Head Neck
publication date: 2022-03-31T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.
PubMed Identifier: 35262203
author list: Rettig EM, Faden DL, Sandhu S, Wong K, Faquin WC, Warinner C, Stephens P, Kumar S, Kuperwasser C, Richmon JD, Uppaluri R, Varvares M, Sethi R, Hanna GJ, Sroussi H
published in: International journal of cancer
information resource reference: Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer. Int J Cancer. 2022 10 01; 151(7):1081-1085.
journal title abbreviation: Int J Cancer
publication date: 2022-03-16T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1449786
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Report of the First International Symposium on NUT Carcinoma.

Report of the First International Symposium on NUT Carcinoma.
PubMed Identifier: 35417004
author list: French CA, Cheng ML, Hanna GJ, DuBois SG, Chau NG, Hann CL, Storck S, Salgia R, Trucco M, Tseng J, Stathis A, Piekarz R, Lauer UM, Massard C, Bennett K, Coker S, Tontsch-Grunt U, Sos ML, Liao S, Wu CJ, Polyak K, Piha-Paul SA, Shapiro GI
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Report of the First International Symposium on NUT Carcinoma. Clin Cancer Res. 2022 06 13; 28(12):2493-2505.
journal title abbreviation: Clin Cancer Res
publication date: 2022-06-13T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma.
PubMed Identifier: 35595174
author list: Liu KX, Milligan MG, Schoenfeld JD, Tishler RB, Ng AK, Devlin PM, Fite E, Rabinowits G, Hanna GJ, Silk AW, Yoon CH, Thakuria M, Margalit DN
published in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
information resource reference: Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma. Radiother Oncol. 2022 08; 173:32-40.
journal title abbreviation: Radiother Oncol
publication date: 2022-05-17T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1451402
type: Authorship
author rank in publication: 9
linked author: Hanna, Glenn
linked information resource: Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma.

Authorship 1451503
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: An Overview of Clinical Oncology and Impact on Oral Health.

Authorship 1452878
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.

Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
PubMed Identifier: 35576437
author list: Berger BM, Hanna GJ, Posner MR, Genden EM, Lautersztain J, Naber SP, Del Vecchio Fitz C, Kuperwasser C
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma. Clin Cancer Res. 2022 10 03; 28(19):4292-4301.
journal title abbreviation: Clin Cancer Res
publication date: 2022-10-03T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

An Overview of Clinical Oncology and Impact on Oral Health.
PubMed Identifier: 35548170
author list: Harris JA, Ottaviani G, Treister NS, Hanna GJ
published in: Frontiers in oral health
information resource reference: An Overview of Clinical Oncology and Impact on Oral Health. Front Oral Health. 2022; 3:874332.
journal title abbreviation: Front Oral Health
publication date: 2022-04-25T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.
PubMed Identifier: 36301568
author list: Rettig EM, Wang AA, Tran NA, Carey E, Dey T, Schoenfeld JD, Sehgal K, Guenette JP, Margalit DN, Sethi R, Uppaluri R, Tishler RB, Annino DJ, Goguen LA, Jo VY, Haddad RI, Hanna GJ
published in: JAMA otolaryngology-- head & neck surgery
information resource reference: Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2022 12 01; 148(12):1120-1130.
journal title abbreviation: JAMA Otolaryngol Head Neck Surg
publication date: 2022-12-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1481294
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.

Authorship 1490617
type: Authorship
author rank in publication: 17
linked author: Hanna, Glenn
linked information resource: Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.

Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.
PubMed Identifier: 36097345
author list: Steeghs N, Hansen AR, Hanna GJ, Garralda E, Park H, Strauss J, Adam M, Campbell G, Carver J, Easton R, Mays K, Skrdla P, Struemper H, Washburn ML, Matheny C, Piha-Paul SA
published in: Clinical and translational science
information resource reference: Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development. Clin Transl Sci. 2022 11; 15(11):2625-2639.
journal title abbreviation: Clin Transl Sci
publication date: 2022-09-12T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1517257
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Systemic and Targeted Therapies in Adenoid Cystic Carcinoma.

Systemic and Targeted Therapies in Adenoid Cystic Carcinoma.
PubMed Identifier: 36637743
author list: Kacew AJ, Hanna GJ
published in: Current treatment options in oncology
information resource reference: Systemic and Targeted Therapies in Adenoid Cystic Carcinoma. Curr Treat Options Oncol. 2023 01; 24(1):45-60.
journal title abbreviation: Curr Treat Options Oncol
publication date: 2023-01-13T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Diagnostic performance of computed tomography features in detecting oropharyngeal squamous cell carcinoma extranodal extension.
PubMed Identifier: 36719493
author list: Tran NA, Palotai M, Hanna GJ, Schoenfeld JD, Bay CP, Rettig EM, Bunch PM, Juliano AF, Kelly HR, Suh CH, Zander DA, Morales Pinzon A, Kann BH, Huang RY, Haddad RI, Guttmann CRG, Guenette JP
published in: European radiology
information resource reference: Diagnostic performance of computed tomography features in detecting oropharyngeal squamous cell carcinoma extranodal extension. Eur Radiol. 2023 May; 33(5):3693-3703.
journal title abbreviation: Eur Radiol
publication date: 2023-01-31T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1522283
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Diagnostic performance of computed tomography features in detecting oropharyngeal squamous cell carcinoma extranodal extension.

Authorship 1528250
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia.

Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia.
PubMed Identifier: 36860910
author list: Hanna GJ, Villa A, Mistry N, Jia Y, Quinn CT, Turner MM, Felt KD, Pfaff K, Haddad RI, Uppaluri R, Rodig SJ, Woo SB, Egloff AM, Hodi FS
published in: Cancer research communications
information resource reference: Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia. Cancer Res Commun. 2021 10; 1(1):30-40.
journal title abbreviation: Cancer Res Commun
publication date: 2021-10-13T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1531740
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia.

Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia.
PubMed Identifier: 36875716
author list: Hanna GJ, Villa A, Mistry N, Jia Y, Quinn CT, Turner MM, Felt KD, Pfaff K, Haddad RI, Uppaluri R, Rodig SJ, Woo SB, Egloff AM, Hodi FS
published in: Cancer research communications
information resource reference: Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia. Cancer Res Commun. 2022 May; 2(5):390.
journal title abbreviation: Cancer Res Commun
publication date: 2022-05-19T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis.
PubMed Identifier: 37148655
author list: Rettig EM, Waterboer T, Sim E, Faden DL, Butt J, Hanna GJ, Del Vecchio Fitz C, Kuperwasser C, Sroussi H
published in: Oral oncology
information resource reference: Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis. Oral Oncol. 2023 06; 141:106417.
journal title abbreviation: Oral Oncol
publication date: 2023-05-04T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1552078
type: Authorship
author rank in publication: 13
linked author: Hanna, Glenn
linked information resource: Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment.

Authorship 1572808
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors.

Authorship 1563150
type: Authorship
author rank in publication: 17
linked author: Hanna, Glenn
linked information resource: Tipifarnib Potentiates the Antitumor Effects of PI3Ka Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.

Authorship 1570043
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.

Authorship 1559858
type: Authorship
author rank in publication: 6
linked author: Hanna, Glenn
linked information resource: Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis.

Authorship 1570445
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: The evolving landscape of salivary gland tumors.

Authorship 1564711
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Personalizing Surveillance in Head and Neck Cancer.

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors.
PubMed Identifier: 37353377
author list: Wala JA, Hanna GJ
published in: Hematology/oncology clinics of North America
information resource reference: Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors. Hematol Oncol Clin North Am. 2023 12; 37(6):1149-1168.
journal title abbreviation: Hematol Oncol Clin North Am
publication date: 2023-06-21T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.
PubMed Identifier: 37284189
author list: Black CM, Hanna GJ, Wang L, Ramakrishnan K, Goto D, Turzhitsky V, Hair GM
published in: Frontiers in oncology
information resource reference: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma. Front Oncol. 2023; 13:1160144.
journal title abbreviation: Front Oncol
publication date: 2023-05-22T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment.
PubMed Identifier: 36990508
author list: McInnis C, Bhatia S, Vijaykumar B, Tian Q, Sun Y, Leistritz-Edwards D, Quinn CT, Uppaluri R, Egloff AM, Srinivasan L, Pregibon DC, Coyle AJ, Hanna GJ
published in: Journal for immunotherapy of cancer
information resource reference: Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment. J Immunother Cancer. 2023 03; 11(3).
journal title abbreviation: J Immunother Cancer
publication date: 2023-03-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Tipifarnib Potentiates the Antitumor Effects of PI3Ka Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
PubMed Identifier: 37339176
author list: Smith AE, Chan S, Wang Z, McCloskey A, Reilly Q, Wang JZ, Patel HV, Koshizuka K, Soifer HS, Kessler L, Dayoub A, Villaflor V, Adkins DR, Bruce JY, Ho AL, Perez CA, Hanna GJ, Gascó Hernández A, Saunders A, Dale S, Gutkind JS, Burrows F, Malik S
published in: Cancer research
information resource reference: Tipifarnib Potentiates the Antitumor Effects of PI3Ka Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity. Cancer Res. 2023 10 02; 83(19):3252-3263.
journal title abbreviation: Cancer Res
publication date: 2023-10-02T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

The evolving landscape of salivary gland tumors.
PubMed Identifier: 37490348
author list: Steuer CE, Hanna GJ, Viswanathan K, Bates JE, Kaka AS, Schmitt NC, Ho AL, Saba NF
published in: CA: a cancer journal for clinicians
information resource reference: The evolving landscape of salivary gland tumors. CA Cancer J Clin. 2023 Nov-Dec; 73(6):597-619.
journal title abbreviation: CA Cancer J Clin
publication date: 2023-07-25T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Personalizing Surveillance in Head and Neck Cancer.
PubMed Identifier: 37079869
author list: Hanna GJ, Patel N, Tedla SG, Baugnon KL, Aiken A, Agrawal N
published in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
information resource reference: Personalizing Surveillance in Head and Neck Cancer. Am Soc Clin Oncol Educ Book. 2023 01; 43:e389718.
journal title abbreviation: Am Soc Clin Oncol Educ Book
publication date: 2023-01-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1592161
type: Authorship
author rank in publication: 14
linked author: Hanna, Glenn
linked information resource: Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.

Authorship 1588166
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.

Authorship 1584392
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.

Authorship 1583925
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.

Authorship 1590331
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.
PubMed Identifier: 37683037
author list: Oliveira G, Egloff AM, Afeyan AB, Wolff JO, Zeng Z, Chernock RD, Zhou L, Messier C, Lizotte P, Pfaff KL, Stromhaug K, Penter L, Haddad RI, Hanna GJ, Schoenfeld JD, Goguen LA, Annino DJ, Jo V, Oppelt P, Pipkorn P, Jackson R, Puram SV, Paniello RC, Rich JT, Webb J, Zevallos JP, Mansour M, Fu J, Dunn GP, Rodig SJ, Ley J, Morris LGT, Dunn L, Paweletz CP, Kallogjeri D, Piccirillo JF, Adkins DR, Wu CJ, Uppaluri R
published in: Science immunology
information resource reference: Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer. Sci Immunol. 2023 09 08; 8(87):eadf4968.
journal title abbreviation: Sci Immunol
publication date: 2023-09-08T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.
PubMed Identifier: 37643133
author list: Hanna GJ, Ahn MJ, Muzaffar J, Keam B, Bowles DW, Wong DJ, Ho AL, Kim SB, Worden F, Yun T, Meng X, Van Tornout JM, Conlan MG, Kang H
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma. Clin Cancer Res. 2023 11 14; 29(22):4555-4563.
journal title abbreviation: Clin Cancer Res
publication date: 2023-11-14T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.
PubMed Identifier: 37529689
author list: Black CM, Hanna GJ, Wang L, Ramakrishnan K, Goto D, Turzhitsky V, Hair GM
published in: Frontiers in oncology
information resource reference: Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma. Front Oncol. 2023; 13:1240947.
journal title abbreviation: Front Oncol
publication date: 2023-07-17T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.
PubMed Identifier: 37712875
author list: Hanna GJ, Stathis A, Lopez-Miranda E, Racca F, Quon D, Leyvraz S, Hess D, Keam B, Rodon J, Ahn MJ, Kim HR, Schneeweiss A, Ribera JM, DeAngelo D, Perez Garcia JM, Cortes J, Schönborn-Kellenberger O, Weber D, Pisa P, Bauer M, Beni L, Bobadilla M, Lehal R, Vigolo M, Vogl FD, Garralda E
published in: Cancer research communications
information resource reference: A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors. Cancer Res Commun. 2023 09 14; 3(9):1853-1861.
journal title abbreviation: Cancer Res Commun
publication date: 2023-09-14T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
PubMed Identifier: 37566241
author list: Hanna GJ, Roof SA, Jabalee J, Rettig EM, Ferrandino R, Chen S, Posner MR, Misiukiewicz KJ, Genden EM, Chai RL, Sims J, Thrash E, Stern SJ, Kalman NS, Yarlagadda S, Raben A, Clements L, Mendelsohn A, Kaczmar JM, Pandey Y, Bhayani M, Gupta P, Kuperwasser C, Del Vecchio Fitz C, Berger BM
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance. Clin Cancer Res. 2023 10 13; 29(20):4306-4313.
journal title abbreviation: Clin Cancer Res
publication date: 2023-10-13T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Otolaryngology Head and Neck Surgery
is primary position: true
position in department: Otolaryngology Head and Neck Surgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Otolaryngology Head and Neck Surgery
position in organization: Massachusetts Eye and Ear Infirmary

Authorship 1601663
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma.

Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma.
PubMed Identifier: 37844691
author list: Kim EY, Ruiz ES, Hanna GJ, Thakuria M, Silk AW
published in: Journal of the American Academy of Dermatology
information resource reference: Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2024 02; 90(2):427-429.
journal title abbreviation: J Am Acad Dermatol
publication date: 2023-10-14T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1610561
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.

Authorship 1611117
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Immunotherapy for head and neck cancer: where do we go from here?

Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
PubMed Identifier: 37971722
author list: Hanna GJ, Villa A, Nandi SP, Shi R, ONeill A, Liu M, Quinn CT, Treister NS, Sroussi HY, Vacharotayangul P, Goguen LA, Annino DJ, Rettig EM, Jo VY, Wong KS, Lizotte P, Paweletz CP, Uppaluri R, Haddad RI, Cohen EEW, Alexandrov LB, William WN, Lippman SM, Woo SB
published in: JAMA oncology
information resource reference: Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 01 01; 10(1):32-41.
journal title abbreviation: JAMA Oncol
publication date: 2024-01-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Immunotherapy for head and neck cancer: where do we go from here?
PubMed Identifier: 38009225
author list: Ko EC, Hanna GJ
published in: Immunotherapy
information resource reference: Immunotherapy for head and neck cancer: where do we go from here? Immunotherapy. 2023 12; 15(18):1497-1500.
journal title abbreviation: Immunotherapy
publication date: 2023-11-27T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1614586
type: Authorship
author rank in publication: 14
linked author: Hanna, Glenn
linked information resource: PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.

PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
PubMed Identifier: 38118249
author list: Ferrarotto R, Swiecicki PL, Zandberg DP, Baiocchi RA, Wesolowski R, Rodriguez CP, McKean M, Kang H, Monga V, Nath R, Palmisiano N, Babbar N, Sun W, Hanna GJ
published in: Oral oncology
information resource reference: PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study. Oral Oncol. 2024 Feb; 149:106634.
journal title abbreviation: Oral Oncol
publication date: 2023-12-20T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1616634
type: Authorship
author rank in publication: 20
linked author: Hanna, Glenn
linked information resource: Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.

Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.
PubMed Identifier: 38154515
author list: Luo J, Sanchez M, Lee E, Hertzler H, Luong N, Mazzola E, Finstein B, Tamen R, Brisbane G, Nguyen T, Paik PK, Chaft JE, Cheng ML, Khalil H, Piha-Paul SA, Sholl LM, Nishino M, Jänne PA, DuBois SG, Hanna GJ, Shapiro GI, French CA
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma. J Thorac Oncol. 2024 May; 19(5):829-838.
journal title abbreviation: J Thorac Oncol
publication date: 2023-12-27T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1618428
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Imaging and Biomarker Surveillance for Head and Neck Squamous Cell Carcinoma: A Systematic Review and American Radium Society Appropriate Use Criteria Statement.

Imaging and Biomarker Surveillance for Head and Neck Squamous Cell Carcinoma: A Systematic Review and American Radium Society Appropriate Use Criteria Statement.
PubMed Identifier: 38168554
author list: Hanna GJ, Chang SS, Siddiqui F, Bain PA, Takiar V, Ward MC, Shukla ME, Hu KS, Robbins J, Witek ME, Bakst R, Chandra RA, Galloway T, Margalit DN
published in: International journal of radiation oncology, biology, physics
information resource reference: Imaging and Biomarker Surveillance for Head and Neck Squamous Cell Carcinoma: A Systematic Review and American Radium Society Appropriate Use Criteria Statement. Int J Radiat Oncol Biol Phys. 2024 Jul 01; 119(3):786-802.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2023-12-31T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1623931
type: Authorship
author rank in publication: 31
linked author: Hanna, Glenn
linked information resource: Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.

Authorship 1622956
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
PubMed Identifier: 38252908
author list: Hanna GJ, Dharanesswaran H, Giobbie-Hurder A, Harran JJ, Liao Z, Pai L, Tchekmedyian V, Ruiz ES, Waldman AH, Schmults CD, Riella LV, Lizotte P, Paweletz CP, Chandraker AK, Murakami N, Silk AW
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol. 2024 Mar 20; 42(9):1021-1030.
journal title abbreviation: J Clin Oncol
publication date: 2024-01-22T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.
PubMed Identifier: 38272561
author list: Huffman BM, Singh H, Ali LR, Horick N, Wang SJ, Hoffman MT, Metayer KA, Murray S, Bird A, Abrams TA, Biller LH, Chan JA, Meyerhardt JA, McCleary NJ, Goessling W, Patel AK, Wisch JS, Yurgelun MB, Mouw K, Reardon B, Van Allen EM, Zerillo JA, Clark JW, Parikh A, Mayer RJ, Schlechter B, Ng K, Kumar S, Del Vecchio Fitz C, Kuperwasser C, Hanna GJ, Coveler AL, Rubinson DA, Welsh EL, Pfaff K, Rodig S, Dougan SK, Cleary JM
published in: Journal for immunotherapy of cancer
information resource reference: Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. J Immunother Cancer. 2024 01 25; 12(1).
journal title abbreviation: J Immunother Cancer
publication date: 2024-01-25T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 1633220
type: Authorship
author rank in publication: 9
linked author: Hanna, Glenn
linked information resource: Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma.

Authorship 1629841
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.

Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.
PubMed Identifier: 38416410
author list: Hanna GJ, Grover P, Elliott A, McGrath J, Xiu J, Sukari A, Johnson JM, Wise-Draper T
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II. Clin Cancer Res. 2024 May 15; 30(10):2225-2232.
journal title abbreviation: Clin Cancer Res
publication date: 2024-05-15T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma.
PubMed Identifier: 38390265
author list: Black CM, Zheng D, Hair GM, Ai L, Wang L, Goto D, Lerman N, Bidadi B, Hanna GJ
published in: Frontiers in oncology
information resource reference: Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma. Front Oncol. 2024; 14:1348045.
journal title abbreviation: Front Oncol
publication date: 2024-02-08T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1638723
type: Authorship
author rank in publication: 5
linked author: Hanna, Glenn
linked information resource: Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma.

Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma.
PubMed Identifier: 38546619
author list: Kim EY, Ruiz ES, DeSimone MS, Shalhout SZ, Hanna GJ, Miller DM, Schmults C, Rettig EM, Foreman RK, Sethi R, Thakuria M, Silk AW
published in: JAMA otolaryngology-- head & neck surgery
information resource reference: Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2024 05 01; 150(5):414-420.
journal title abbreviation: JAMA Otolaryngol Head Neck Surg
publication date: 2024-05-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1649233
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Cancer Precursor Syndromes and Their Detection in the Head and Neck.

Cancer Precursor Syndromes and Their Detection in the Head and Neck.
PubMed Identifier: 38705773
author list: Villa A, William WN, Hanna GJ
published in: Hematology/oncology clinics of North America
information resource reference: Cancer Precursor Syndromes and Their Detection in the Head and Neck. Hematol Oncol Clin North Am. 2024 08; 38(4):813-830.
journal title abbreviation: Hematol Oncol Clin North Am
publication date: 2024-05-04T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1656596
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma.

Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma.
PubMed Identifier: 38824449
author list: Hanna GJ, Dennis MJ, Scarfo N, Mullin MS, Sethi RKV, Sehgal K, Annino DJ, Goguen LA, Haddad RI, Tishler RB, Margalit DN, Uppaluri R, Schoenfeld JD, Rettig EM
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2024 Aug 01; 30(15):3329-3336.
journal title abbreviation: Clin Cancer Res
publication date: 2024-08-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1662612
type: Authorship
author rank in publication: 22
linked author: Hanna, Glenn
linked information resource: Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance.

Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance.
PubMed Identifier: 38878355
author list: Roof SA, Jabalee J, Rettig EM, Chennareddy S, Ferrandino RM, Chen S, Posner MR, Genden EM, Chai RL, Sims J, Thrash E, Stern SJ, Kalman NS, Yarlagadda S, Raben A, Clements L, Mendelsohn A, Kaczmar JM, Pandey Y, Bhayani M, Del Vecchio Fitz C, Hanna GJ
published in: Oral oncology
information resource reference: Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance. Oral Oncol. 2024 Aug; 155:106874.
journal title abbreviation: Oral Oncol
publication date: 2024-06-14T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Pathology
is primary position: true
position in department: Pathology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Pathology
position in organization: Massachusetts General Hospital

Associate Professor of Surgery
is primary position: true
position in department: Surgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Surgery
position in organization: Beth Israel Deaconess Medical Center

Associate Professor of Surgery
is primary position: true
position in department: Surgery
position in division: Vascular Surgery
sort order: 1
type: Position
HR job title: Associate Professor of Surgery
position in organization: Beth Israel Deaconess Medical Center

Authorship 1684367
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer.

Authorship 1684321
type: Authorship
author rank in publication: 6
linked author: Hanna, Glenn
linked information resource: Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC.

Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer.
PubMed Identifier: 39159525
author list: Hanna GJ, Jabalee J, Lukens JN, Sun L, Rettig EM, Ferrandino R, Posner MR, Misiukiewicz KJ, Routman DM, Van Abel KM, Del Vecchio Fitz C, Roof SA
published in: Oral oncology
information resource reference: Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer. Oral Oncol. 2024 Nov; 158:107002.
journal title abbreviation: Oral Oncol
publication date: 2024-08-18T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC.
PubMed Identifier: 39158913
author list: Sun L, Cohen RB, D'Avella CA, Singh AP, Schoenfeld JD, Hanna GJ
published in: JAMA network open
information resource reference: Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC. JAMA Netw Open. 2024 08 01; 7(8):e2428526.
journal title abbreviation: JAMA Netw Open
publication date: 2024-08-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 660192
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Pathology quiz case 2. Solitary fibrous tumor (SFT) of the hypopharynx.

Authorship 648392
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?

Pathology quiz case 2. Solitary fibrous tumor (SFT) of the hypopharynx.
PubMed Identifier: 21844422
author list: Hanna GJ, Grant N, Wycherly B
published in: Archives of otolaryngology--head & neck surgery
information resource reference: Pathology quiz case 2. Solitary fibrous tumor (SFT) of the hypopharynx. Arch Otolaryngol Head Neck Surg. 2011 Aug; 137(8):830; author reply 833-4.
journal title abbreviation: Arch Otolaryngol Head Neck Surg
publication date: 2011-08-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1702443
type: Authorship
author rank in publication: 19
linked author: Hanna, Glenn
linked information resource: Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma.

Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma.
PubMed Identifier: 39438862
author list: Dennis MJ, Pavlick DC, Kacew A, Wotman M, MacConaill LE, Jones SM, Pfaff KL, Rodig SJ, Eacker S, Malig M, Reister E, Piccioni D, Kesari S, Sehgal K, Haddad RI, Cohen E, Posner MR, Deichaite I, Hanna GJ
published in: Journal of translational medicine
information resource reference: Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma. J Transl Med. 2024 Oct 22; 22(1):960.
journal title abbreviation: J Transl Med
publication date: 2024-10-22T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.
PubMed Identifier: 39625478
author list: Hanna GJ, Oakley LB, Shi R, ONeill A, Shin KY, Scarfo N, Sehgal K, Dennis MJ, Quinn N, Jo VY, Wong K, Shvyrkova A, Kushnarev V, Shanthappa BU, Tkachuk A, Kryukov K, Sarachakov A, Svekolkin V, Lennerz J, Waters S, Haddad RI
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2025 Feb 17; 31(4):619-627.
journal title abbreviation: Clin Cancer Res
publication date: 2025-02-17T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.
PubMed Identifier: 39715483
author list: Rettig EM, Schoenfeld JD, Miller J, Sargent B, Carey E, Margalit DN, Sehgal K, Sethi RKV, Uppaluri R, Tishler RB, Goguen LA, Annino DJ, Sim ES, Jo VY, Wong KS, Guenette JP, Haddad RI, Hanna GJ
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA. Clin Cancer Res. 2025 May 01; 31(9):1605-1614.
journal title abbreviation: Clin Cancer Res
publication date: 2025-05-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S.
PubMed Identifier: 39754998
author list: Hanna GJ, Zheng D, Gao W, Hair GM, Ai L, Song Y, Lerman N, Bidadi B, Zion A, Zou L, Tang Y, Wang L, Merchant S, Black CM
published in: Oral oncology
information resource reference: PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S. Oral Oncol. 2025 Feb; 161:107146.
journal title abbreviation: Oral Oncol
publication date: 2025-01-03T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

T cell dynamics with neoadjuvant immunotherapy in head and neck cancer.
PubMed Identifier: 39658611
author list: Zhao M, Schoenfeld JD, Egloff AM, Hanna GJ, Haddad RI, Adkins DR, Uppaluri R
published in: Nature reviews. Clinical oncology
information resource reference: T cell dynamics with neoadjuvant immunotherapy in head and neck cancer. Nat Rev Clin Oncol. 2025 Feb; 22(2):83-94.
journal title abbreviation: Nat Rev Clin Oncol
publication date: 2024-12-10T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1717516
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S.

Authorship 1720959
type: Authorship
author rank in publication: 18
linked author: Hanna, Glenn
linked information resource: A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.

Authorship 1715551
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: T cell dynamics with neoadjuvant immunotherapy in head and neck cancer.

Professor of Radiation Oncology
is primary position: true
position in department: Radiation Oncology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Radiation Oncology
position in organization: Brigham and Women's Hospital

Neurosurgery
type: Department
type: Organization

Authorship 1733851
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.

Authorship 1733476
type: Authorship
author rank in publication: 5
linked author: Hanna, Glenn
linked information resource: First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours.

Authorship 1733758
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Authorship 1729257
type: Authorship
author rank in publication: 27
linked author: Hanna, Glenn
linked information resource: First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer.

First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours.
PubMed Identifier: 39886141
author list: Naing A, Papadopoulos KP, Pishvaian MJ, Rahma O, Hanna GJ, Garralda E, Saavedra O, Gogov S, Kallender H, Cheng L, Smith M, Chen X, Kuriakose E, Bauer T
published in: BMJ oncology
information resource reference: First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours. BMJ Oncol. 2024; 3(1):e000249.
journal title abbreviation: BMJ Oncol
publication date: 2024-05-09T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.
PubMed Identifier: 39900969
author list: Luo J, Bishop JA, DuBois SG, Hanna GJ, Sholl LM, Stelow EB, Thompson LDR, Shapiro GI, French CA
published in: Nature reviews. Clinical oncology
information resource reference: Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck. Nat Rev Clin Oncol. 2025 Apr; 22(4):292-306.
journal title abbreviation: Nat Rev Clin Oncol
publication date: 2025-02-03T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer.
PubMed Identifier: 39948608
author list: Shapiro RM, Sheffer M, Booker MA, Tolstorukov MY, Birch GC, Sade-Feldman M, Fang J, Li S, Lu W, Ansuinelli M, Dulery R, Tarannum M, Baginska J, Dwivedi N, Kothari A, Penter L, Abdulhamid YZ, Kaplan IE, Khanhlinh D, Uppaluri R, Redd RA, Nikiforow S, Koreth J, Ritz J, Wu CJ, Soiffer RJ, Hanna GJ, Romee R
published in: Journal of hematology & oncology
information resource reference: First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer. J Hematol Oncol. 2025 Feb 14; 18(1):17.
journal title abbreviation: J Hematol Oncol
publication date: 2025-02-14T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1741808
type: Authorship
author rank in publication: 3
linked author: Hanna, Glenn
linked information resource: Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Narrative Review.

Authorship 1743120
type: Authorship
author rank in publication: 11
linked author: Hanna, Glenn
linked information resource: Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challenges.

Authorship 1742626
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Authorship 1744459
type: Authorship
author rank in publication: 7
linked author: Hanna, Glenn
linked information resource: Artificial Intelligence Measured Tumor Burden and Pre-Treatment Circulating Tumor DNA in Human Papilloma Virus-Associated Oropharynx Cancer.

Authorship 1748274
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Corrigendum to "PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S." [Oral Oncol. 161 (2025) 107146].

Authorship 1747712
type: Authorship
author rank in publication: 8
linked author: Hanna, Glenn
linked information resource: Paranasal Sinus and Nasal Cavity Cancers: Systematic Review and Executive Summary of the American Radium Society Appropriate Use Criteria.

Paranasal Sinus and Nasal Cavity Cancers: Systematic Review and Executive Summary of the American Radium Society Appropriate Use Criteria.
PubMed Identifier: 40344605
author list: Witek ME, Ward MC, Bakst R, Chandra RA, Chang SS, Choi KY, Galloway T, Hanna GJ, Hu KS, Robbins J, Shukla ME, Siddiqui F, Takiar V, Walker GV, Fu Y, Margalit DN
published in: Head & neck
information resource reference: Paranasal Sinus and Nasal Cavity Cancers: Systematic Review and Executive Summary of the American Radium Society Appropriate Use Criteria. Head Neck. 2025 Aug; 47(8):2073-2091.
journal title abbreviation: Head Neck
publication date: 2025-05-09T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Artificial Intelligence Measured Tumor Burden and Pre-Treatment Circulating Tumor DNA in Human Papilloma Virus-Associated Oropharynx Cancer.
PubMed Identifier: 40322795
author list: Bakhtiar M, Ye Z, Schoenfeld JD, Mohammadi H, Guenette JP, Rettig EM, Hanna GJ, Kann BH
published in: Head & neck
information resource reference: Artificial Intelligence Measured Tumor Burden and Pre-Treatment Circulating Tumor DNA in Human Papilloma Virus-Associated Oropharynx Cancer. Head Neck. 2025 Oct; 47(10):2641-2649.
journal title abbreviation: Head Neck
publication date: 2025-05-05T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Narrative Review.
PubMed Identifier: 40048196
author list: Sim ES, Nguyen HCB, Hanna GJ, Uppaluri R
published in: JAMA otolaryngology-- head & neck surgery
information resource reference: Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Narrative Review. JAMA Otolaryngol Head Neck Surg. 2025 May 01; 151(5):521-528.
journal title abbreviation: JAMA Otolaryngol Head Neck Surg
publication date: 2025-05-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.
PubMed Identifier: 40277179
author list: Hanna GJ, Cote GM, Chugh R, Thomas JS, Malhotra J, Cutler RE, Hood T, Carvajal LA, Olek EA, Villalona-Calero MA
published in: Cancer research communications
information resource reference: Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma. Cancer Res Commun. 2025 May 01; 5(5):767-773.
journal title abbreviation: Cancer Res Commun
publication date: 2025-05-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challenges.
PubMed Identifier: 40294876
author list: Jiménez-Labaig P, Lorini L, Gurizzan C, Kinloch E, Burton S, Forster MD, Metcalf R, Ferrarotto R, Bossi P, O Leary B, Hanna G, Felip E, Garcia IB, Harrington KJ
published in: Critical reviews in oncology/hematology
information resource reference: Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challenges. Crit Rev Oncol Hematol. 2025 Jul; 211:104747.
journal title abbreviation: Crit Rev Oncol Hematol
publication date: 2025-04-26T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Corrigendum to "PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S." [Oral Oncol. 161 (2025) 107146].
PubMed Identifier: 40221270
author list: Hanna GJ, Zheng D, Gao W, Hair GM, Ai L, Song Y, Lerman N, Bidadi B, Zion A, Zou L, Tang Y, Wang L, Merchant S, Black CM
published in: Oral oncology
information resource reference: Corrigendum to "PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S." [Oral Oncol. 161 (2025) 107146]. Oral Oncol. 2025 Oct; 169:107292.
journal title abbreviation: Oral Oncol
publication date: 2025-04-11T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1752686
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: The Challenge and Promise of Circulating Tumor HPV DNA for Minimal Residual Disease Detection-Catching the Unseen.

The Challenge and Promise of Circulating Tumor HPV DNA for Minimal Residual Disease Detection-Catching the Unseen.
PubMed Identifier: 40402546
author list: Lee NY, Hanna GJ, Faden DL
published in: JAMA otolaryngology-- head & neck surgery
information resource reference: The Challenge and Promise of Circulating Tumor HPV DNA for Minimal Residual Disease Detection-Catching the Unseen. JAMA Otolaryngol Head Neck Surg. 2025 Jul 01; 151(7):672-674.
journal title abbreviation: JAMA Otolaryngol Head Neck Surg
publication date: 2025-07-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Otolaryngology Head and Neck Surgery
is primary position: true
position in department: Otolaryngology Head and Neck Surgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Otolaryngology Head and Neck Surgery
position in organization: Dana-Farber Cancer Institute

Associate Professor of Otolaryngology Head and Neck Surgery
is primary position: true
position in department: Otolaryngology Head and Neck Surgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Otolaryngology Head and Neck Surgery
position in organization: Massachusetts Eye and Ear Infirmary

Authorship 1815011
type: Authorship
author rank in publication: 6
linked author: Hanna, Glenn
linked information resource: Lenalidomide for the Treatment of Chronic Oral Mucositis and Soft Tissue Necrosis After Radiation Therapy.

Authorship 1823631
type: Authorship
author rank in publication: 5
linked author: Hanna, Glenn
linked information resource: Current Trends in the Management of Recurrent Nasopharyngeal Carcinoma.

Authorship 1826292
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Access to head and neck cancer specialists: a geospatial analysis of U.S. travel time.

Authorship 1831398
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Outcomes of oropharyngeal squamous cell carcinoma among patients with lymphoproliferative disorders.

Authorship 1833561
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: International network for sinonasal cancer research (INSICA): a collaborative group to advance research and clinical trials for rare sinonasal malignancies.

Authorship 1834245
type: Authorship
author rank in publication: 9
linked author: Hanna, Glenn
linked information resource: Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review.

Authorship 1834445
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

Authorship 1835173
type: Authorship
author rank in publication: 8
linked author: Hanna, Glenn
linked information resource: Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.

Authorship 1846252
type: Authorship
author rank in publication: 4
linked author: Hanna, Glenn
linked information resource: Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors.

Authorship 1848859
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Elraglusib, a Glycogen Synthase Kinase 3ß Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.

Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.
PubMed Identifier: 41520892
author list: So J, Droznin AD, Tiwari P, Chen YH, Chau NG, Margalit DN, Tishler RB, Hanna GJ, Mak RH, Fitzgerald KJ, Sehgal K, Li S, Gunasti L, Kim E, Minken J, Baginska J, Nau A, Diaz IG, Shim B, Janes JT, Uppaluri R, Haddad RI, Livak KJ, Schoenfeld JD
published in: International journal of radiation oncology, biology, physics
information resource reference: Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2026 May 01; 125(1):64-77.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2026-01-09T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Access to head and neck cancer specialists: a geospatial analysis of U.S. travel time.
PubMed Identifier: 40823090
author list: Goodnight BL, Hanna GJ, Zheng D, Habila M, Cassese M, Fortman A, Walbert H, Sieling F, Black CM
published in: Frontiers in oncology
information resource reference: Access to head and neck cancer specialists: a geospatial analysis of U.S. travel time. Front Oncol. 2025; 15:1521370.
journal title abbreviation: Front Oncol
publication date: 2025-07-31T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Lenalidomide for the Treatment of Chronic Oral Mucositis and Soft Tissue Necrosis After Radiation Therapy.
PubMed Identifier: 41720302
author list: Pettas E, Woo SB, Margalit DN, Tishler RB, Haddad RI, Hanna GJ, Treister NS
published in: Practical radiation oncology
information resource reference: Lenalidomide for the Treatment of Chronic Oral Mucositis and Soft Tissue Necrosis After Radiation Therapy. Pract Radiat Oncol. 2026 Feb 18.
journal title abbreviation: Pract Radiat Oncol
publication date: 2026-02-18T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Current Trends in the Management of Recurrent Nasopharyngeal Carcinoma.
PubMed Identifier: 40539461
author list: Pandrangi VC, Liao JJ, de Almeida JR, El-Sayed IH, Hanna G, Su SY, Tsang R, Won TB, Witterick I, Choby G, Kuan EC, Geltzeiler M
published in: Head & neck
information resource reference: Current Trends in the Management of Recurrent Nasopharyngeal Carcinoma. Head Neck. 2025 Sep; 47(9):2611-2621.
journal title abbreviation: Head Neck
publication date: 2025-06-20T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors.
PubMed Identifier: 40713179
author list: Milhem MM, Wise-Draper TM, Chandra S, Hanna GJ, Laux DE, Medina TM, Ansstas G, Daud A, Kelly CM, O'Day SJ, Perez CA, Wong MK, Friedlander PA, Kristedja TS, Burgess MA, Cowey CL, Hanks BA, Weight RM, Daniel WL, Feltner DE, Mix S, Sindelar L, Bexon AS, Bexon MF, Michel RE, Bhatia S
published in: Journal for immunotherapy of cancer
information resource reference: Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors. J Immunother Cancer. 2025 Jul 25; 13(7).
journal title abbreviation: J Immunother Cancer
publication date: 2025-07-25T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review.
PubMed Identifier: 41629764
author list: Ward MC, Kang JJ, Saba NF, Campbell SR, Akhave NS, Chang SS, Spencer SA, Spreafico A, Hanna GJ, Yom SS, Heron DE
published in: Journal of the National Cancer Institute
information resource reference: Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review. J Natl Cancer Inst. 2026 Feb 02.
journal title abbreviation: J Natl Cancer Inst
publication date: 2026-02-02T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

International network for sinonasal cancer research (INSICA): a collaborative group to advance research and clinical trials for rare sinonasal malignancies.
PubMed Identifier: 41405839
author list: London NR, Hanna GJ, Akhave NS, Choby G, Devriese LA, Ferrand FR, Gallia GL, Li L, Moya-Plana A, Rehman U, Takeda T, Thariat J, Woods RSR, Verillaud B, Lechner M
published in: Journal of the National Cancer Institute
information resource reference: International network for sinonasal cancer research (INSICA): a collaborative group to advance research and clinical trials for rare sinonasal malignancies. J Natl Cancer Inst. 2025 Dec 17.
journal title abbreviation: J Natl Cancer Inst
publication date: 2025-12-17T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Elraglusib, a Glycogen Synthase Kinase 3ß Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.
PubMed Identifier: 41065505
author list: Hanna GJ, Scarfo N, Shin KY, O'Neill A, Bedard V, Dennis MJ, Sehgal K, Jo VY, Wong K, Ugolkov A, Mazar A, Haddad RI
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Elraglusib, a Glycogen Synthase Kinase 3ß Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma. Clin Cancer Res. 2026 Jan 06; 32(1):83-93.
journal title abbreviation: Clin Cancer Res
publication date: 2026-01-06T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Outcomes of oropharyngeal squamous cell carcinoma among patients with lymphoproliferative disorders.
PubMed Identifier: 41129864
author list: Williams MM, Hanna GJ, Sethi RK, Rettig EM
published in: Oral oncology
information resource reference: Outcomes of oropharyngeal squamous cell carcinoma among patients with lymphoproliferative disorders. Oral Oncol. 2025 Nov; 170:107761.
journal title abbreviation: Oral Oncol
publication date: 2025-10-22T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
PubMed Identifier: 41746627
author list: Hanna GJ, Zamulko OY, Grover P, Adkins DR, Oppelt PJ, Romano AE, Lehn MA, Bachmann LM, Wikenheiser-Brokamp KA, Lemmon CA, Forsythe AJ, Allen CL, Pan J, Rai SN, El-Gamal D, Wise-Draper TM
published in: JAMA otolaryngology-- head & neck surgery
information resource reference: Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026 Apr 01; 152(4):376-383.
journal title abbreviation: JAMA Otolaryngol Head Neck Surg
publication date: 2026-04-01T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Anaesthesia
is primary position: true
position in department: Anaesthesia
position in division: Cardiovascular
sort order: 1
type: Position
HR job title: Associate Professor of Anaesthesia
position in organization: Massachusetts General Hospital

Assistant Professor of Otolaryngology Head and Neck Surgery
is primary position: true
position in department: Otolaryngology Head and Neck Surgery
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Assistant Professor of Otolaryngology Head and Neck Surgery
position in organization: Dana-Farber Cancer Institute

Authorship 762205
type: Authorship
author rank in publication: 12
linked author: Hanna, Glenn
linked information resource: Response and acquired resistance to everolimus in anaplastic thyroid cancer.

Response and acquired resistance to everolimus in anaplastic thyroid cancer.
PubMed Identifier: 25295501
author list: Wagle N, Grabiner BC, Van Allen EM, Amin-Mansour A, Taylor-Weiner A, Rosenberg M, Gray N, Barletta JA, Guo Y, Swanson SJ, Ruan DT, Hanna GJ, Haddad RI, Getz G, Kwiatkowski DJ, Carter SL, Sabatini DM, Jänne PA, Garraway LA, Lorch JH
published in: The New England journal of medicine
information resource reference: Response and acquired resistance to everolimus in anaplastic thyroid cancer. N Engl J Med. 2014 Oct 09; 371(15):1426-33.
journal title abbreviation: N Engl J Med
publication date: 2014-10-09T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 799874
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Genomic analysis of metastatic cutaneous squamous cell carcinoma.

Genomic analysis of metastatic cutaneous squamous cell carcinoma.
PubMed Identifier: 25589618
author list: Li YY, Hanna GJ, Laga AC, Haddad RI, Lorch JH, Hammerman PS
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res. 2015 Mar 15; 21(6):1447-56.
journal title abbreviation: Clin Cancer Res
publication date: 2015-01-14T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 878498
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience.

Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience.
PubMed Identifier: 26614576
author list: Lorch JH, Hanna GJ, Posner MR, O'Neill A, Thotakura VL, Limaye SA, Rabinowits G, Sher DJ, Tishler RB, Haddad RI
published in: Head & neck
information resource reference: Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience. Head Neck. 2016 04; 38 Suppl 1:E1618-24.
journal title abbreviation: Head Neck
publication date: 2015-11-28T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor
sort order: 2
type: Faculty Rank

Associate Professor
sort order: 1
type: Faculty Rank

Full Professor
sort order: 0
type: Faculty Rank

Other Faculty
sort order: 5
type: Faculty Rank

Authorship 930691
type: Authorship
author rank in publication: 5
linked author: Hanna, Glenn
linked information resource: Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.

Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.
PubMed Identifier: 27797976
author list: Gibson WJ, Ruan DT, Paulson VA, Barletta JA, Hanna GJ, Kraft S, Calles A, Nehs MA, Moore FD, Taylor-Weiner A, Wala JA, Zack TI, Lee TC, Fennessy FM, Alexander EK, Thomas T, Janne PA, Garraway LA, Carter SL, Beroukhim R, Lorch JH, Van Allen EM
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer. Clin Cancer Res. 2017 May 01; 23(9):2367-2373.
journal title abbreviation: Clin Cancer Res
publication date: 2016-10-17T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Richmon, Jeremy
eCommons Login: JDR20
first name: Jeremy
last name: Richmon
full name: Jeremy D. Richmon, M.D.
has faculty rank: Associate Professor
Person ID: 30121
person in primary position: Associate Professor of Otolaryngology Head and Neck Surgery
type: Agent
type: Person
preferred title: Associate Professor of Otolaryngology Head and Neck Surgery

Uppaluri, Ravindra
eCommons Login: RU17
first name: Ravindra
last name: Uppaluri
full name: Ravindra Uppaluri, M.D., Ph.D.
has faculty rank: Full Professor
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 155890
person in primary position: Professor of Otolaryngology Head and Neck Surgery
type: Agent
type: Person
preferred title: Professor of Otolaryngology Head and Neck Surgery

Authorship 969371
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.
PubMed Identifier: 28209748
author list: Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H
published in: The oncologist
information resource reference: The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 03; 22(3):343-350.
journal title abbreviation: Oncologist
publication date: 2017-02-16T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 974179
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.

Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.
PubMed Identifier: 28351582
author list: Hanna GJ, Liu H, Jones RE, Bacay AF, Lizotte PH, Ivanova EV, Bittinger MA, Cavanaugh ME, Rode AJ, Schoenfeld JD, Chau NG, Haddad RI, Lorch JH, Wong KK, Uppaluri R, Hammerman PS
published in: Oral oncology
information resource reference: Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2017 04; 67:61-69.
journal title abbreviation: Oral Oncol
publication date: 2017-02-14T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 976590
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.

Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.
PubMed Identifier: 28387659
author list: Hanna GJ, Sridharan V, Margalit DN, La Follette SK, Chau NG, Rabinowits G, Lorch JH, Haddad RI, Tishler RB, Anderson KS, Schoenfeld JD
published in: Cancer biomarkers : section A of Disease markers
information resource reference: Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma. Cancer Biomark. 2017; 19(2):129-136.
journal title abbreviation: Cancer Biomark
publication date: 2017-01-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

450 Brookline Ave
type: Address
address line 1: Dana-Farber Cancer Institute
address line 3: 450 Brookline Ave
city: Boston
postal code: 02215
state or province: MA

Authorship 1013962
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.

Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
PubMed Identifier: 28939078
author list: Hanna GJ, Adkins DR, Zolkind P, Uppaluri R
published in: Oral oncology
information resource reference: Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma. Oral Oncol. 2017 10; 73:65-69.
journal title abbreviation: Oral Oncol
publication date: 2017-08-17T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1022985
type: Authorship
author rank in publication: 43
linked author: Hanna, Glenn
linked information resource: Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.
PubMed Identifier: 29101162
author list: Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA
published in: Cancer discovery
information resource reference: Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov. 2018 02; 8(2):196-215.
journal title abbreviation: Cancer Discov
publication date: 2017-11-03T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1024554
type: Authorship
author rank in publication: 2
linked author: Hanna, Glenn
linked information resource: The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.
PubMed Identifier: 29123016
author list: Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H
published in: The oncologist
information resource reference: The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 11; 22(11):1413.
journal title abbreviation: Oncologist
publication date: 2017-11-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Unresolved, atraumatic breast hematoma: post-irradiation or secondary breast angiosarcoma.
PubMed Identifier: 22377611
author list: Hanna G, Lin SJ, Wertheimer MD, Sharma R
published in: Breast disease
information resource reference: Unresolved, atraumatic breast hematoma: post-irradiation or secondary breast angiosarcoma. Breast Dis. 2011; 33(3):139-42.
journal title abbreviation: Breast Dis
publication date: 2011-01-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1036502
type: Authorship
author rank in publication: 1
linked author: Hanna, Glenn
linked information resource: Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.
PubMed Identifier: 29301825
author list: Hanna GJ, Busaidy NL, Chau NG, Wirth LJ, Barletta JA, Calles A, Haddad RI, Kraft S, Cabanillas ME, Rabinowits G, O'Neill A, Limaye SA, Alexander EK, Moore FD, Misiwkeiwicz K, Thomas T, Nehs M, Marqusee E, Lee SL, Jänne PA, Lorch JH
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study. Clin Cancer Res. 2018 04 01; 24(7):1546-1553.
journal title abbreviation: Clin Cancer Res
publication date: 2018-01-04T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Cardiovascular
type: Division
type: Organization

Frameshift events predict anti-PD-1/L1 response in head and neck cancer.
PubMed Identifier: 29467336
author list: Hanna GJ, Lizotte P, Cavanaugh M, Kuo FC, Shivdasani P, Frieden A, Chau NG, Schoenfeld JD, Lorch JH, Uppaluri R, MacConaill LE, Haddad RI
published in: JCI insight
information resource reference: Frameshift events predict anti-PD-1/L1 response in head and neck cancer. JCI Insight. 2018 02 22; 3(4).
journal title abbreviation: JCI Insight
publication date: 2018-02-22T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?
PubMed Identifier: 23442306
author list: Hanna GJ, Haddad RI, Lorch JH
published in: The oncologist
information resource reference: Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future? Oncologist. 2013; 18(3):288-93.
journal title abbreviation: Oncologist
publication date: 2013-02-26T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource